ETX0282 is an orally available, broad spectrum inhibitor of class A and C beta-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
Molecular Weight:
315.3
CAS Number:
[2209871-83-8]
Formula:
C13H18FN3O5
Target:
Others
T69797
* VAT and and shipping costs not included. Errors and price changes excepted